Back to top
more

HealthStream (HSTM)

(Delayed Data from NSDQ)

$28.87 USD

28.87
374,492

+0.28 (0.98%)

Updated Aug 21, 2026 04:00 PM ET

After-Market: $28.84 -0.03 (-0.10%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (168 out of 247)

Industry: Internet - Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

HSTM vs. SHOP: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

HSTM vs. SHOP: Which Stock Is the Better Value Option?

Zacks Equity Research

Akamai Introduces ISV Catalyst to Accelerate Cloud Growth

by Zacks Equity Research

AKAM launches ISV Catalyst, a referral-based partner program that cuts first-year fees and helps ISVs build, market and sell on its global cloud.

Zacks Equity Research

HSTM or SHOP: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

HSTM vs. SHOP: Which Stock Is the Better Value Option?

David Bartosiak headshot

Bear of the Day: The Trade Desk (TTD)

by David Bartosiak

This used to be one of most popular stocks to talk about. Now the talk is all bearish.

Zacks Equity Research

HealthStream (HSTM) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

HealthStream (HSTM) delivered earnings and revenue surprises of +17.65% and +0.96%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Akamai and LevelBlue Launch Managed Web App, API Protection Services

by Zacks Equity Research

AKAM joins forces with LevelBlue to launch an AI-powered managed WAAP service, tackling surging web app and API security challenges worldwide.

Zacks Equity Research

HealthStream (HSTM) Surpasses Q2 Earnings Estimates

by Zacks Equity Research

HealthStream (HSTM) delivered earnings and revenue surprises of +12.50% and -0.49%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Indrajit Bandyopadhyay headshot

OPRX Delivers Solid Q1 Earnings: But Can It Sustain the Momentum?

by Indrajit Bandyopadhyay

OptimizeRx posts 11% Q1 growth and rising EBITDA, but long-term momentum hinges on scaling subscriptions and margin mix gains.

Indrajit Bandyopadhyay headshot

OptimizeRx Bets on AI and Workflow Integration: Will This Pay Off?

by Indrajit Bandyopadhyay

OPRX doubles down on AI and subscriptions, but margin mix and retention risks loom over its platform transformation.

Indrajit Bandyopadhyay headshot

Does DOCS' Shift Toward Enterprise Offerings Signal a Long-Term Pivot?

by Indrajit Bandyopadhyay

DOCS sharpens its enterprise focus with AI and workflow tools, signaling a deeper pivot beyond pharma marketing roots.